 |
|
Prophylactic Photocoagulation of Recurrent Toxoplasmic RetinochoroiditisA Preliminary Report
HAROLD F. SPALTER, MD;
CHARLES J. CAMPBELL, MD;
KIMIHARU S. NOYORI, MD;
M. CATHERINE RITTLER, AB;
CHARLES J. KOESTER
Arch Ophthalmol. 1966;75(1):21-31.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
Since the recognition of the toxoplasma parasite as a common cause of posterior uveitis, a major effort has been directed toward the management of this often visually disabling disease. One of the outstanding characteristics of ocular toxoplasmosis and perhaps the most difficult to control is the tendency of the active disease process to recur. Chemotherapy may shorten the duration of the inflammatory process, but once the retinal tissue is actively involved, permanent loss of local retinal function can often be anticipated. Recurrence of a perimacular inactive lesion with extension into the macular area can convert an eye with perfect vision into one without useful acuity. Marked vitreous reaction secondary to reactivation of even a small peripheral retinochoroidal scar can produce disturbing visual symptoms or become disabling, if the affected eye is the only useful eye.
This clinical investigation, therefore, was undertaken to evaluate the effects of photocoagulation on the prevention
. . . [Full Text PDF of this Article]
Author Affiliations
New York
From the Institute of Ophthalmology of Presbyterian Hospital, College of Physicians and Surgeons of Columbia University, and the Research Division, American Optical Company (Dr. Koester), New York.
Footnotes
Submitted for publication May 12, 1965.
Reprint requests to Institute of Ophthalmology, 635 W 165th St, New York 10032.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
